+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nanomedicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Nanomedicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Nanomedicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 180 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5614336
Free Webex Call
10% Free customization
Description Jump to:

Nanoparticles is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Nanomedicine Market, valued at USD 174.10 Billion in 2024, is projected to experience a CAGR of 9.10% to reach USD 293.59 Billion by 2030. Nanomedicine represents the application of nanotechnology in healthcare, utilizing materials and devices typically ranging from 1 to 100 nanometers for the diagnosis, treatment, and prevention of diseases. This approach leverages the unique properties of nanoscale structures to enhance drug solubility, stability, targeted delivery, and bioavailability.

Key Market Drivers

The global nanomedicine market experiences significant impetus from two primary factors: ongoing advancements in nanotechnology innovation and the increasing prevalence of chronic diseases. Technological progress consistently yields novel tools and materials, enabling sophisticated diagnostic and therapeutic applications within healthcare. For instance, according to the National Institutes of Health, in July 2023, the Notice of Funding Opportunity for "Innovative Research in Cancer Nanotechnology (IRCN) R01 Grant" was published, with application deadlines including November 2023 and May 2024, demonstrating sustained investment in fundamental research in this specialized area. Concurrently, the rising global burden of chronic diseases intensifies the demand for more effective medical interventions.

Key Market Challenges

A significant challenge impeding the expansion of the Global Nanomedicine Market is the substantial cost associated with the development and complex manufacturing processes of these specialized products. The intricate nature of nanotechnology-based interventions necessitates considerable upfront investment in research, highly specialized equipment, advanced infrastructure, and a workforce with unique expertise. These requirements often lead to protracted development timelines and increased operational expenditures throughout the product lifecycle, from initial synthesis to large-scale production.

Key Market Trends

The increasing shift towards personalized nanomedicine stands as a significant factor shaping the global nanomedicine market. This trend emphasizes tailoring medical treatments to individual patient characteristics, leveraging nanotechnology's ability to deliver drugs precisely and enhance diagnostic accuracy. Personalized nanomedicine offers the potential for improved therapeutic efficacy and reduced adverse effects by targeting specific cells or tissues. According to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U. S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. This demonstrates a growing regulatory recognition and market adoption of personalized approaches, which nanomedicine profoundly supports.

Key Market Players Profiled:

  • Pfizer Inc.
  • Johnson & Johnson Innovative Medicine
  • Sanofi S.A.
  • Amgen Inc.
  • Moderna, Inc.
  • Novo Nordisk A/S
  • Genentech, Inc.
  • Celgene Corporation
  • Vifor Pharma Group
  • Teva Pharmaceutical Industries Ltd.

Report Scope:

In this report, the Global Nanomedicine Market has been segmented into the following categories:

By Nanomolecule Type:

  • Nanoparticles
  • Nanoshells
  • Nanodevices
  • Nanotubes

By Nanoparticles Type:

  • Polymer-based
  • Lipid-based
  • Nanocrystals
  • Inorganic
  • Others

By Application:

  • Drug Delivery
  • Vaccines
  • Diagnostic Imaging
  • Regenerative Medicine
  • Others

By Disease Indication:

  • Oncological Diseases
  • Infectious Diseases
  • Orthopedic Disorders
  • Cardiovascular Diseases
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nanomedicine Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Nanomedicine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
5.2.2. By Nanoparticles Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others)
5.2.3. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
5.2.4. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Nanomedicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Nanomolecule Type
6.2.2. By Nanoparticles Type
6.2.3. By Application
6.2.4. By Disease Indication
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Nanomedicine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Nanomolecule Type
6.3.1.2.2. By Nanoparticles Type
6.3.1.2.3. By Application
6.3.1.2.4. By Disease Indication
6.3.2. Canada Nanomedicine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Nanomolecule Type
6.3.2.2.2. By Nanoparticles Type
6.3.2.2.3. By Application
6.3.2.2.4. By Disease Indication
6.3.3. Mexico Nanomedicine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Nanomolecule Type
6.3.3.2.2. By Nanoparticles Type
6.3.3.2.3. By Application
6.3.3.2.4. By Disease Indication
7. Europe Nanomedicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Nanomolecule Type
7.2.2. By Nanoparticles Type
7.2.3. By Application
7.2.4. By Disease Indication
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nanomedicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Nanomolecule Type
7.3.1.2.2. By Nanoparticles Type
7.3.1.2.3. By Application
7.3.1.2.4. By Disease Indication
7.3.2. France Nanomedicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Nanomolecule Type
7.3.2.2.2. By Nanoparticles Type
7.3.2.2.3. By Application
7.3.2.2.4. By Disease Indication
7.3.3. United Kingdom Nanomedicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Nanomolecule Type
7.3.3.2.2. By Nanoparticles Type
7.3.3.2.3. By Application
7.3.3.2.4. By Disease Indication
7.3.4. Italy Nanomedicine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Nanomolecule Type
7.3.4.2.2. By Nanoparticles Type
7.3.4.2.3. By Application
7.3.4.2.4. By Disease Indication
7.3.5. Spain Nanomedicine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Nanomolecule Type
7.3.5.2.2. By Nanoparticles Type
7.3.5.2.3. By Application
7.3.5.2.4. By Disease Indication
8. Asia-Pacific Nanomedicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Nanomolecule Type
8.2.2. By Nanoparticles Type
8.2.3. By Application
8.2.4. By Disease Indication
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Nanomedicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Nanomolecule Type
8.3.1.2.2. By Nanoparticles Type
8.3.1.2.3. By Application
8.3.1.2.4. By Disease Indication
8.3.2. India Nanomedicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Nanomolecule Type
8.3.2.2.2. By Nanoparticles Type
8.3.2.2.3. By Application
8.3.2.2.4. By Disease Indication
8.3.3. Japan Nanomedicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Nanomolecule Type
8.3.3.2.2. By Nanoparticles Type
8.3.3.2.3. By Application
8.3.3.2.4. By Disease Indication
8.3.4. South Korea Nanomedicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Nanomolecule Type
8.3.4.2.2. By Nanoparticles Type
8.3.4.2.3. By Application
8.3.4.2.4. By Disease Indication
8.3.5. Australia Nanomedicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Nanomolecule Type
8.3.5.2.2. By Nanoparticles Type
8.3.5.2.3. By Application
8.3.5.2.4. By Disease Indication
9. Middle East & Africa Nanomedicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Nanomolecule Type
9.2.2. By Nanoparticles Type
9.2.3. By Application
9.2.4. By Disease Indication
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Nanomedicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Nanomolecule Type
9.3.1.2.2. By Nanoparticles Type
9.3.1.2.3. By Application
9.3.1.2.4. By Disease Indication
9.3.2. UAE Nanomedicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Nanomolecule Type
9.3.2.2.2. By Nanoparticles Type
9.3.2.2.3. By Application
9.3.2.2.4. By Disease Indication
9.3.3. South Africa Nanomedicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Nanomolecule Type
9.3.3.2.2. By Nanoparticles Type
9.3.3.2.3. By Application
9.3.3.2.4. By Disease Indication
10. South America Nanomedicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Nanomolecule Type
10.2.2. By Nanoparticles Type
10.2.3. By Application
10.2.4. By Disease Indication
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanomedicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Nanomolecule Type
10.3.1.2.2. By Nanoparticles Type
10.3.1.2.3. By Application
10.3.1.2.4. By Disease Indication
10.3.2. Colombia Nanomedicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Nanomolecule Type
10.3.2.2.2. By Nanoparticles Type
10.3.2.2.3. By Application
10.3.2.2.4. By Disease Indication
10.3.3. Argentina Nanomedicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Nanomolecule Type
10.3.3.2.2. By Nanoparticles Type
10.3.3.2.3. By Application
10.3.3.2.4. By Disease Indication
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Nanomedicine Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Pfizer Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Johnson & Johnson Innovative Medicine
15.3. Sanofi S.A.
15.4. Amgen Inc.
15.5. Moderna, Inc.
15.6. Novo Nordisk A/S
15.7. Genentech, Inc.
15.8. Celgene Corporation
15.9. Vifor Pharma Group
15.10. Teva Pharmaceutical Industries Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Nanomedicine market report include:
  • Pfizer Inc.
  • Johnson & Johnson Innovative Medicine
  • Sanofi S.A.
  • Amgen Inc.
  • Moderna, Inc.
  • Novo Nordisk A/S
  • Genentech, Inc.
  • Celgene Corporation
  • Vifor Pharma Group
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 174.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 293.59 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Nanomedicine Market - Global Forecast 2025-2032 - Product Image

Nanomedicine Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Nanomedicine - Global Strategic Business Report - Product Image

Nanomedicine - Global Strategic Business Report

  • Report
  • 339 Pages
  • Global
From
Nanomedicine Market Size, Share, Trends and Forecast by Nanomolecule Type, Product, Application, and Region, 2025-2033 - Product Image

Nanomedicine Market Size, Share, Trends and Forecast by Nanomolecule Type, Product, Application, and Region, 2025-2033

  • Report
  • 147 Pages
  • Global
From
Nanomedicine Market Report 2025 - Product Image

Nanomedicine Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Nanomedicine Drug Delivery Global Market Report 2025 - Product Image

Nanomedicine Drug Delivery Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.